NEW YORK, July 9 - Sequenom has agreed to exclusively license HiberGen's SNaPIT genotyping technology for use with its MassArray mass spectrometry platform, the companies said Monday.

The license will allow San Diego-based Sequenom to develop and commercialize reagents and software for the MassArray system using HiberGen's technology. In return, Sequenom will pay HiberGen a license fee and royalties from sales of any SNaPIT-related products that Sequenom develops.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.